The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
ZYN pouches contain no tobacco, only nicotine, offering a potentially less harmful option for tobacco users, with lower ...
Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
Friday's Forbes Daily covers a billionaire's plans for a legendary Las Vegas property, what's next for the TikTok ban, Musk and Bezos apparently make amends and more ...
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
In a groundbreaking move for the industry, the FDA has authorized the marketing of ZYN nicotine pouches — the first product ...
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products ...
The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but ...
The Food and Drug Administration has authorized the sales of 20 types of ZYN nicotine pouches amid concerns about children ...
The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.” ...